[HTML] mdpi.com

[HTML][HTML] Fats, friends or foes: investigating the role of short-and medium-chain fatty acids in Alzheimer's disease

AO Ameen, K Freude, BI Aldana - Biomedicines, 2022 - mdpi.com
Characterising Alzheimer's disease (AD) as a metabolic disorder of the brain is gaining
acceptance based on the pathophysiological commonalities between AD and major …
被引用次数：7 相关文章

Fats, Friends or Foes: Investigating the Role of Short-and Medium-Chain Fatty Acids in Alzheimer's Disease

AO Ameen, K Freude, BI Aldana - 2022 - agris.fao.org
Characterising Alzheimer's disease (AD) as a metabolic disorder of the brain is gaining
acceptance based on the pathophysiological commonalities between AD and major …
[HTML] nih.gov

[HTML][HTML] Fats, Friends or Foes: Investigating the Role of Short-and Medium-Chain Fatty Acids in Alzheimer's Disease

AO Ameen, K Freude, BI Aldana - Biomedicines, 2022 - ncbi.nlm.nih.gov
Characterising Alzheimer's disease (AD) as a metabolic disorder of the brain is gaining
acceptance based on the pathophysiological commonalities between AD and major …

Fats, Friends or Foes: Investigating the Role of Short-and Medium-Chain Fatty Acids in Alzheimer's Disease

AO Ameen, K Freude, BI Aldana - Biomedicines, 2022 - pubmed.ncbi.nlm.nih.gov
Characterising Alzheimer's disease (AD) as a metabolic disorder of the brain is gaining
acceptance based on the pathophysiological commonalities between AD and major …

Fats, Friends or Foes: Investigating the Role of Short-and Medium-Chain Fatty Acids in Alzheimer's Disease.

AO Ameen, K Freude, BI Aldana - Biomedicines, 2022 - search.ebscohost.com
Characterising Alzheimer's disease (AD) as a metabolic disorder of the brain is gaining
acceptance based on the pathophysiological commonalities between AD and major …

Fats, Friends or Foes: Investigating the Role of Short-and Medium-Chain Fatty Acids in Alzheimer's Disease.

AO Ameen, K Freude, BI Aldana - Biomedicines, 2022 - europepmc.org
Characterising Alzheimer's disease (AD) as a metabolic disorder of the brain is gaining
acceptance based on the pathophysiological commonalities between AD and major …

Fats, Friends or Foes: Investigating the Role of Short-and Medium-Chain Fatty Acids in Alzheimer's Disease

AO Ameen, K Freude, BI Aldana - Biomedicines, 2022 - search.proquest.com
Characterising Alzheimer's disease (AD) as a metabolic disorder of the brain is gaining
acceptance based on the pathophysiological commonalities between AD and major …

Fats, Friends or Foes: Investigating the Role of Short-and Medium-Chain Fatty Acids in Alzheimer's Disease.

AO Ameen, K Freude, BI Aldana - Biomedicines, 2022 - europepmc.org
Characterising Alzheimer's disease (AD) as a metabolic disorder of the brain is gaining
acceptance based on the pathophysiological commonalities between AD and major …